Global Market Report on Equols, 2026–2032
2026年 1月 27日(火曜日) 18:54
Total Global Market Size of Equols
Equol is a compound that is produced when daidzein, a component of soy isoflavones, is metabolized by intestinal bacteria. Because it has a stronger effect than soy isoflavones alone, it has been discovered that equol is the source of power that supports women.
Figure: Product Image of a Equols
Key Drivers of the Market
1、Accumulation of Scientific Evidence and Rising Awareness: As an intestinal metabolite of soy isoflavones, equol's efficacy in alleviating menopausal symptoms and maintaining bone density has been reported in clinical studies worldwide, enhancing its recognition and credibility among both physicians and consumers.
2、Aging Society's Demand for Extended Healthy Lifespan: Against the backdrop of global population aging, the potential of equol to improve the quality of life for post-menopausal women is expanding its market as a preventive healthcare solution.
3、Adoption in Foods for Specified Health Uses (FOSHU): In Japan, products containing equol that have obtained FOSHU approval with claims such as "helps maintain bone health" and "alleviates symptoms associated with menopausal fluctuations" have entered the market. The reliability conferred by national review has driven substantial market growth.
According to the latest report titled “Global Market Share and Ranking of Leading Companies in Equols (2026)” released by the YHResearch research team, the global Equols market is projected to grow from USD 15.5 million in 2025 to USD 23.6 million by 2031, with a compound annual growth rate (CAGR) of 7.2% during 2025–2031.
The report provides a comprehensive analysis of the current status and future trends of the global Equols market, helping stakeholders understand market size by product type, application, company, region, and country.
Future Development Potential
1、Integrated Solutions for "Equol Non-Producers": For individuals who cannot produce equol themselves ("non-producers"), a significant growth opportunity lies not only in direct equol supplementation but also in combined products with probiotics and prebiotics aimed at improving gut microbiota and enhancing endogenous production capacity.
2、Exploring Men's Health and Beauty Markets: If research progresses on equol's potential effects on prostate health, hair loss prevention, and other men's health and beauty concerns, it could unlock a new consumer segment capable of doubling the market size.
3、Expanding Anti-Aging Demand to Younger and Middle-Aged Demographics: By strengthening scientific evidence for equol's beauty benefits, such as promoting collagen production related to skin moisturization and elasticity, it becomes possible to capture anti-aging demand not only from menopausal groups but also from younger and middle-aged populations.
Key Challenges Hindering Market Growth
1、Individual Variation in Production Capacity and Inconsistent Effects: Due to differences in gut microbiota, there are "equol producers" and "non-producers" in the population. The fact that benefits are not uniformly experienced by all creates a barrier to conviction and widespread adoption among both consumers and healthcare professionals.
2、Limitations in Long-Term Safety Data: Compared to pharmaceuticals, evidence regarding the long-term safety of equol intake is relatively limited, leading to cautious attitudes among some conservative healthcare providers and consumers.
3、Limited Insurance Coverage and Disparities in Medical Community Awareness: Equol is not approved as a pharmaceutical, thus it is not covered by insurance. Furthermore, not all physicians are aware of or recommend it based on the evidence, which limits its dissemination through medical channels.
This article introduces the report published by YH Research: "Global Equols Market Share and Ranking 2026."
◇For detailed report information and to request a free sample, please visit: https://www.yhresearch.co.jp/reports/1095196/equols
Company Overview
YH Research is a market research and information services company that supports global business. The company provides services that help businesses grow and develop, including industry research reports, custom reports, IPO advisory services, and business plan creation. With offices in five countries worldwide, YH Research delivers accurate and valuable data to companies in over 100 countries, supporting them in quickly responding to market changes through industry trend analysis, competitive analysis, and consumer behavior analysis.
【Contact Information】
YH Research
Address: 5-12-4-1203 Kachidoki, Chuo-ku, Tokyo, Japan
TEL：050-5840-2692（Japan）；0081-5058402692（Global）
Contact us：info@yhresearch.com
URL：https://www.yhresearch.com
Equol is a compound that is produced when daidzein, a component of soy isoflavones, is metabolized by intestinal bacteria. Because it has a stronger effect than soy isoflavones alone, it has been discovered that equol is the source of power that supports women.
Figure: Product Image of a Equols
Key Drivers of the Market
1、Accumulation of Scientific Evidence and Rising Awareness: As an intestinal metabolite of soy isoflavones, equol's efficacy in alleviating menopausal symptoms and maintaining bone density has been reported in clinical studies worldwide, enhancing its recognition and credibility among both physicians and consumers.
2、Aging Society's Demand for Extended Healthy Lifespan: Against the backdrop of global population aging, the potential of equol to improve the quality of life for post-menopausal women is expanding its market as a preventive healthcare solution.
3、Adoption in Foods for Specified Health Uses (FOSHU): In Japan, products containing equol that have obtained FOSHU approval with claims such as "helps maintain bone health" and "alleviates symptoms associated with menopausal fluctuations" have entered the market. The reliability conferred by national review has driven substantial market growth.
According to the latest report titled “Global Market Share and Ranking of Leading Companies in Equols (2026)” released by the YHResearch research team, the global Equols market is projected to grow from USD 15.5 million in 2025 to USD 23.6 million by 2031, with a compound annual growth rate (CAGR) of 7.2% during 2025–2031.
The report provides a comprehensive analysis of the current status and future trends of the global Equols market, helping stakeholders understand market size by product type, application, company, region, and country.
Future Development Potential
1、Integrated Solutions for "Equol Non-Producers": For individuals who cannot produce equol themselves ("non-producers"), a significant growth opportunity lies not only in direct equol supplementation but also in combined products with probiotics and prebiotics aimed at improving gut microbiota and enhancing endogenous production capacity.
2、Exploring Men's Health and Beauty Markets: If research progresses on equol's potential effects on prostate health, hair loss prevention, and other men's health and beauty concerns, it could unlock a new consumer segment capable of doubling the market size.
3、Expanding Anti-Aging Demand to Younger and Middle-Aged Demographics: By strengthening scientific evidence for equol's beauty benefits, such as promoting collagen production related to skin moisturization and elasticity, it becomes possible to capture anti-aging demand not only from menopausal groups but also from younger and middle-aged populations.
Key Challenges Hindering Market Growth
1、Individual Variation in Production Capacity and Inconsistent Effects: Due to differences in gut microbiota, there are "equol producers" and "non-producers" in the population. The fact that benefits are not uniformly experienced by all creates a barrier to conviction and widespread adoption among both consumers and healthcare professionals.
2、Limitations in Long-Term Safety Data: Compared to pharmaceuticals, evidence regarding the long-term safety of equol intake is relatively limited, leading to cautious attitudes among some conservative healthcare providers and consumers.
3、Limited Insurance Coverage and Disparities in Medical Community Awareness: Equol is not approved as a pharmaceutical, thus it is not covered by insurance. Furthermore, not all physicians are aware of or recommend it based on the evidence, which limits its dissemination through medical channels.
This article introduces the report published by YH Research: "Global Equols Market Share and Ranking 2026."
◇For detailed report information and to request a free sample, please visit: https://www.yhresearch.co.jp/reports/1095196/equols
Company Overview
YH Research is a market research and information services company that supports global business. The company provides services that help businesses grow and develop, including industry research reports, custom reports, IPO advisory services, and business plan creation. With offices in five countries worldwide, YH Research delivers accurate and valuable data to companies in over 100 countries, supporting them in quickly responding to market changes through industry trend analysis, competitive analysis, and consumer behavior analysis.
【Contact Information】
YH Research
Address: 5-12-4-1203 Kachidoki, Chuo-ku, Tokyo, Japan
TEL：050-5840-2692（Japan）；0081-5058402692（Global）
Contact us：info@yhresearch.com
URL：https://www.yhresearch.com
登録者：krystal414
カテゴリー:
商品紹介
